Radiopharm Theranostics Limited ADR (RADX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -24,831 | -31,445 |
| Depreciation Amortization | 1,681 | 2,050 |
| Accounts receivable | -6,096 | 2,283 |
| Accounts payable and accrued liabilities | 333 | 2,295 |
| Other Working Capital | -3,853 | 4,626 |
| Other Operating Activity | 9,033 | 5,123 |
| Operating Cash Flow | $-23,732 | $-15,068 |
| Cash Flows From Investing Activities | ||
| Purchase Sale Intangibles | 1,941 | N/A |
| Other Investing Activity | 1,147 | 0 |
| Investing Cash Flow | $1,147 | $N/A |
| Cash Flows From Financing Activities | ||
| Debt Issued | N/A | 4,833 |
| Debt Repayment | -1,230 | -3,389 |
| Common Stock Issued | 34,956 | 19,442 |
| Other Financing Activity | -4,304 | -1,292 |
| Financing Cash Flow | $29,422 | $19,593 |
| Exchange Rate Effect | -10 | -16 |
| Beginning Cash Position | 12,029 | 7,672 |
| End Cash Position | 18,856 | 12,182 |
| Net Cash Flow | $6,827 | $4,509 |
| Free Cash Flow | ||
| Operating Cash Flow | -23,732 | -15,068 |
| Free Cash Flow | -23,732 | -15,068 |